E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia

British Journal of Haematology

Volumn 114, Issue 3, 2001, Pages 635-637

  Roman, Jose ^a,c   Jimenez, Antonio ^b   Barrios, Manuel ^b   Castillejo, Juan Antonio ^a   Maldonado, Juan ^b   Torres, Antonio ^a  

^a Hospital Universitario Reina Sofia Cordoba   (Argentina)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

BCR ABL; CML; PCR; Ph chromosome

Indexed keywords

BCR ABL PROTEIN;

AGED; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; EXON; FEMALE; GENE DELETION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HYBRID GENE; LABORATORY TEST; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKOCYTE COUNT; PHILADELPHIA CHROMOSOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034797894     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02971.x     Document Type: Article

References (12)

1. The molecular biology of chronic myeloid leukemia
2. Bcr-Abl with and SH3 deletion retains the ability to induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy
3. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2
4. BCR-ABL variants
5. Signal transducer and activator of transcription (STAT) 5 activation by BCR/ABL is dependent on intact Scr homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
6. Chronic myelogenous leukaemia with p185 BCR-ABL expression: Characteristics and clinical significance
7. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia
8. The SH3 domain contributes to BCR/ABL-dependent leukemo-genesis in vivo: Role in adhesion, invasion and homing
9. A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia
10. Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patients
11. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
12. Are aberrant BCR-ABL transcripts more common than previously thought?